Informatie:
Fout:
ID
38381
Beschrijving
A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01425996
Link
https://clinicaltrials.gov/show/NCT01425996
Trefwoorden
Versies (1)
- 14-10-19 14-10-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
14 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Carcinoma, Hepatocellular NCT01425996
Eligibility Carcinoma, Hepatocellular NCT01425996
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Hepatocellular NCT01425996
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age
Item
females or males 20-70 years of age (inclusive)
boolean
C0001779 (UMLS CUI [1])
Liver carcinoma | Condition Other
Item
patients with histological confirmed hcc or other conditions
boolean
C2239176 (UMLS CUI [1])
C0348080 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0348080 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Liver carcinoma Advanced Locally | Portal vein Tumor thrombus | Tumor thrombus Inappropriate Local Therapy
Item
patients with locally advanced hcc and pvtt that is not suitable for other local therapies
boolean
C2239176 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1305775 (UMLS CUI [2,1])
C3163918 (UMLS CUI [2,2])
C3163918 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1517925 (UMLS CUI [3,3])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1305775 (UMLS CUI [2,1])
C3163918 (UMLS CUI [2,2])
C3163918 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1517925 (UMLS CUI [3,3])
Inclusion criteria Additional
Item
other inclusion criteria also apply
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Pregnancy, Planned | Childbearing Potential Contraceptive methods Absent
Item
females who are pregnant/lactating or planning to be pregnant, or patients of childbearing potential who are not using medically recognized method of contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
Neoplasm Metastasis Extrahepatic
Item
patients with documented extrahepatic metastasis
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,2])
Encephalopathy Stage | Tense ascites
Item
patients with stage iii-iv encephalopathy or tense ascites
boolean
C0085584 (UMLS CUI [1,1])
C1306673 (UMLS CUI [1,2])
C0741244 (UMLS CUI [2])
C1306673 (UMLS CUI [1,2])
C0741244 (UMLS CUI [2])
Local Therapy Liver carcinoma | Systemic therapy Liver carcinoma
Item
patients who have received any local or systemic therapy for hcc within 4 weeks prior to the initiation of study treatment
boolean
C1517925 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C2239176 (UMLS CUI [2,2])
C2239176 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C2239176 (UMLS CUI [2,2])
Lipotecan
Item
patients who have received lipotecan® treatment prior to the initiation of study treatment
boolean
C2698966 (UMLS CUI [1])
Exclusion Criteria Additional
Item
other exclusion criteria also apply
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])